The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives

por de Hora, Mark, Heather, Natasha, Webster, Dianne, Albert, Benjamin, Hofman, Paul
Publicado 2023

Introduction of a Protocol for Structured Follow-Up and Texting of Inadequate and Borderline-Positive Newborn Metabolic Screening Results

por Heather, Natasha, Morgan, Lisa, Knoll, Detlef, Shore, Keith, de Hora, Mark, Webster, Dianne
Publicado 2022

Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience

por Heather, Natasha, de Hora, Mark, Brothers, Shannon, Grainger, Pippa, Knoll, Detlef, Webster, Dianne
Publicado 2022

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand

por de Hora, Mark R., Heather, Natasha L., Webster, Dianne R., Albert, Benjamin B., Hofman, Paul L.
Publicado 2022

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand

por de Hora, Mark R., Heather, Natasha L., Patel, Tejal, Bresnahan, Lauren G., Webster, Dianne, Hofman, Paul L.
Publicado 2020

The risk of classical galactosaemia in newborns with borderline galactose metabolites on newborn screening

por Bernhardt, Isaac, Glamuzina, Emma, Ryder, Bryony, Knoll, Detlef, Heather, Natasha, De Hora, Mark, Webster, Dianne, Wilson, Callum
Publicado 2022